Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Sarah Curtis, MPH

Researcher
Eli Lilly and Company, United States

Eli Lilly and Company (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

Using Bias Correction Methods with Hybrid Randomized Controlled Trial (RCT) Plus Real World (RW) Controls to Replicate Results of a Phase Iib RCT of Baricitinib for Rheumatoid Arthritis (RA)
Friday, August 26, 2022
1:30 PM – 1:45 PM CEST